EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Targeting the SND1-MTDH/FANCD2 axis impairs DNA repair and sensitizes triple-negative breast cancer to PARP inhibitor

Zhibi Zhang, Mengdie Ta, Linyuan Shi, Xueqin Dai, Yajuan Chen, Chenglong Pan, Ziyu Zhang, Yanping Chen, Chunyan Wang, Wen Liu, Ceshi Chen, Longlong Zhang

Pharmacological Research · 2026-11 · 109741

DOI: 10.1016/j.phrs.2026.109741 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacological Research, 2026-11. Verfasst von Zhibi Zhang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Yunnan Key Laboratory of Breast Cancer Precision Medicine, School of Biomedical Engineering, Kunming Medical University, Kunming 650500, China. Die Arbeit nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

DDRDP3FANCD2MTDHPARPiSND1

Autor:innen und Institutionen

  • Yunnan Key Laboratory of Breast Cancer Precision Medicine, School of Biomedical Engineering, Kunming Medical University, Kunming 650500, China.
  • Department of Breast Pathology and Lab, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Breast Cance…
  • Fujian Provincial Key Laboratory of Innovative Drug Target Research, School of Pharmaceutical Sciences, Faculty of Medicine and Life Sciences, Xiamen University, Xiamen 361102, China.
  • Yunnan Key Laboratory of Breast Cancer Precision Medicine, School of Biomedical Engineering, Kunming Medical University, Kunming 650500, China; Yunnan Key Laboratory of Breast Cancer Precision Medicine, The Third Affili…
  • Yunnan Key Laboratory of Breast Cancer Precision Medicine, School of Biomedical Engineering, Kunming Medical University, Kunming 650500, China. Electronic address: zhanglonglong@kmmu.edu.cn.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Zhang, Z., Ta, M., Shi, L., Dai, X., Chen, Y., Pan, C., Zhang, Z., Chen, Y., Wang, C., Liu, W., Chen, C., & Zhang, L. (2026). Targeting the SND1-MTDH/FANCD2 axis impairs DNA repair and sensitizes triple-negative breast cancer to PARP inhibitor. Pharmacological Research, 109741. https://doi.org/10.1016/j.phrs.2026.109741

Vancouver

Zhang Z, Ta M, Shi L, Dai X, Chen Y, Pan C, et al. Targeting the SND1-MTDH/FANCD2 axis impairs DNA repair and sensitizes triple-negative breast cancer to PARP inhibitor. Pharmacological Research. 2026:109741. doi:10.1016/j.phrs.2026.109741

BibTeX
@article{Zhang2026,
  author = {Zhang, Zhibi and Ta, Mengdie and Shi, Linyuan and Dai, Xueqin and Chen, Yajuan and Pan, Chenglong and Zhang, Ziyu and Chen, Yanping and Wang, Chunyan and Liu, Wen and Chen, Ceshi and Zhang, Longlong},
  title = {Targeting the SND1-MTDH/FANCD2 axis impairs DNA repair and sensitizes triple-negative breast cancer to PARP inhibitor},
  journal = {Pharmacological Research},
  year = {2026},
  pages = {109741},
  doi = {10.1016/j.phrs.2026.109741}
}
Kostenlos starten →